ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2014

Feb 11, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD RESEARCH CORP (ARWR)
CIK: 0000879407
Period of Report: 2014-02-06

Reporting Person: PERRY MICHAEL S (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-02-06	Common Stock	A	15000	—	Acquired	15000	Direct

Footnotes

F1: Represents shares underlying restricted stock unit, which shares will vest on the one year anniversary of the date of grant.

F2: Not applicable.